π Laurus Labs β Breakout / MSCI Watch
$LAURUSLABS Important Levels: Support: βΉ1,500 β βΉ1,470 Resistance: βΉ1,560 β βΉ1,600 Structure: Strong medium-term trend with fresh institutional catalyst Business: Pharmaceutical and biotechnology company with strong exposure to APIs, formulations and CDMO businesses. Increasing exposure to global pharmaceutical supply chains. Earnings / Trigger: Laurus Labs has been selected for inclusion in the MSCI India Standard Index effective 1 September 2026. Reuters estimates potential passive inflows of around $598 million, making the stock an important institutional-flow candidate. Verdict: π Pharma + institutional-flow theme π Watch βΉ1,560ββΉ1,600 for breakout confirmation
#PersonalFinance#Post-ClosingCommentary
831 likesΒ·67 comments

















